Kolexia
Lervat Cyril Pédiatrie
Lervat Cyril
Pédiatrie
Centre Oscar-Lambret
Lille, France
90 Activités
2 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Ostéosarcome Tumeurs osseuses Sarcomes Récidive tumorale locale Sarcome d'Ewing Métastase tumorale Tumeur de Wilms Tumeurs du poumon Tumeurs du rein

Collaborateurs

Voir plus
Marec-Berard Perrine
Marec-Berard Perrine
Centre Léon-Bérard, Lyon, France
Gaspar Nathalie
Gaspar Nathalie
Gustave-Roussy, Villejuif, France
Entz-Werle Natacha
Entz-Werle Natacha
Hôpital Hautepierre, Strasbourg, France
Piperno-Neumann Sophie
Piperno-Neumann Sophie
Clcc Institut Curie, Paris, France

Industries

Voir plus
Eusa Pharma
2 collaboration(s)
Dernière en 2019
Pfizer
1 collaboration(s)
Dernière en 2019
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
OS2006 : Protocole de Traitement Des ostéosarcomes de l'Enfant, de l'Adolescent et de l'Adulte Comportant
Essai Clinique (Chugai)   09 janvier 2024
E7080-G000-231: An Open-Label, Multicenter Phase 2 Basket Study to Evaluate the Antitumor Activity and Safety of Lenvatinib in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Malignancies
Essai Clinique (Merck & Co.)   08 janvier 2024
ctDNA quantification improves estimation of outcomes in patients with high grade osteosarcoma: a translational study from the OS2006 trial.
Annals of oncology : official journal of the European Society for Medical Oncology   22 décembre 2023
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma: A Phase 2 Study of XL184 (Cabozantinib) in Treating Patients With Relapsed Osteosarcomas and Ewing Sarcomas
Essai Clinique (National Cancer Institute)   28 octobre 2023
MetroWilms: Phase 1-2 Trial Evaluating Metronomic Chemotherapy in Patients With a Relapsed or Refractory Wilms Tumor
Essai Clinique (Centre Oscar-Lambret)   13 octobre 2023
A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma: A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE)
Essai Clinique (Eisai)   10 octobre 2023
Uncommon metachronous multiple sites recurrences of metastatic osteosarcoma cured by surgery: a case report.
Acta oncologica (Stockholm, Sweden)   14 août 2023
REGOSTA: A Randomized, Placebo-controlled, Double-blinded, Multicentre Study Evaluating the Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
Essai Clinique (Centre Léon-Bérard)   07 août 2023
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma: Phase 1/2 Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
Essai Clinique (Eisai)   26 juin 2023